Moreover, using mass spectrometry in the glomeruli of DDD, Sethi and co-workers could not detect CFB components despite the presence of alternative pathway component (C3), terminal complement complex (C5b-9), and its two fluid phase regulators: clusterin and vitronectin [31]. Here, C3 is linked to Dowling-Degos disease 1.